Cosmo Pharmaceuticals N.V. (COPN.SW)
CHF 59.0
(-1.17%)
CHF 59.0
(-1.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 33.62 Million | 33.22 Million | 12.61 Million | 12.98 Million | -18.84 Million | -10.16 Million |
| Net Income | 1.53 Million | 24.47 Million | 24 Million | -6.93 Million | -21.3 Million | -17.45 Million |
| Depreciation & Amortization | 14.26 Million | 13.85 Million | 7.36 Million | 6.03 Million | 10 Thousand | 4.48 Million |
| Deferred income taxes | - | - | -21.36 Million | 5.87 Million | 9.29 Million | - |
| Stock-based compensation | 3.82 Million | 2.07 Million | 1.45 Million | 8.99 Million | 10.08 Million | 9.58 Million |
| Change in working capital | 946 Thousand | -13.31 Million | -5.07 Million | -5.13 Million | -9.02 Million | -3.45 Million |
| Other non-cash items | 13.2 Million | 6.13 Million | 6.21 Million | 4.15 Million | -7.9 Million | -3.32 Million |
| Investing Cash Flow | 42.3 Million | 1.68 Million | 24.85 Million | 75.44 Million | -48.68 Million | -71.78 Million |
| Investments in PPE | -15.31 Million | -7.31 Million | -8.5 Million | -8.08 Million | -17.31 Million | -9.67 Million |
| Acquisitions | -2 Million | - | 23.33 Million | -4.12 Million | 15.06 Million | -79 Thousand |
| Investment purchases | -60.95 Million | -54.04 Million | -1 Million | -20.01 Million | -89.83 Million | -176.02 Million |
| Sales/Maturities of investments | 117.73 Million | 35.91 Million | 7.73 Million | 131.61 Million | 68.16 Million | 111.17 Million |
| Other Investing Activities | 45.65 Million | 27.13 Million | 3.28 Million | -23.94 Million | -24.77 Million | 2.82 Million |
| Financing Cash Flow | -211.26 Million | -46.13 Million | -27.24 Million | -11.88 Million | -34.46 Million | 144.39 Million |
| Debt repayment | -176.02 Million | -916 Thousand | -2.62 Million | -1.78 Million | -1.75 Million | -665 Thousand |
| Dividends payments | -16.89 Million | -15.6 Million | - | - | - | - |
| Common Stock Repurchased | -12.47 Million | -24.74 Million | -19.74 Million | -10.97 Million | -25.33 Million | -18.35 Million |
| Common Stock Issuance | 687 Thousand | 270 Thousand | 761 Thousand | 5.25 Million | - | - |
| Other Financing Activities | -2 Million | -5.13 Million | -4.87 Million | -4.37 Million | -7.37 Million | 163.4 Million |
| Accounts receivables | 5.19 Million | -14.16 Million | 3.29 Million | -7.91 Million | -3.71 Million | 628 Thousand |
| Accounts payables | - | 14.16 Million | -3.29 Million | 7.91 Million | 3.71 Million | - |
| Inventory | -2.7 Million | 1.62 Million | -6.07 Million | 436 Thousand | -2.2 Million | -696 Thousand |
| Other working capital | -301 Thousand | -14.93 Million | 1 Million | -5.57 Million | -6.82 Million | -2.75 Million |
| Cash at beginning of period | 185.82 Million | 198.56 Million | 185.93 Million | 110.38 Million | 210.68 Million | 144.94 Million |
| Cash at end of period | 50.27 Million | 185.82 Million | 198.56 Million | 185.93 Million | 110.38 Million | 210.68 Million |
| Capital Expenditure | -15.31 Million | -7.31 Million | -8.5 Million | -8.08 Million | -17.31 Million | -9.67 Million |
| Effect of forex changes on cash | -210 Thousand | -1.51 Million | 2.4 Million | -997 Thousand | 1.69 Million | 3.29 Million |
| Net cash flow / Change in cash | -135.55 Million | -12.73 Million | 12.62 Million | 75.55 Million | -100.3 Million | 65.74 Million |
| Free Cash Flow | 18.31 Million | 25.91 Million | 4.1 Million | 4.9 Million | -36.16 Million | -19.83 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 37.99 Million | 37.99 Million | 1.53 Million | -3.2 Million | -3.2 Million | 743 Thousand |
| Depreciation & Amortization | 3.64 Million | 3.64 Million | 14.26 Million | 3.67 Million | 3.67 Million | 3.45 Million |
| Deferred income taxes | - | - | - | - | - | -10.27 Million |
| Stock-based compensation | 401.5 Thousand | 401.5 Thousand | 3.82 Million | 1.33 Million | 1.33 Million | 578.5 Thousand |
| Change in working capital | 1.36 Million | 1.36 Million | 946 Thousand | 420.5 Thousand | 420.5 Thousand | 674.5 Thousand |
| Other non-cash items | 6.18 Million | 6.18 Million | 13.2 Million | 6.84 Million | 6.84 Million | 2.29 Million |
| Investing Cash Flow | -44.74 Million | -44.74 Million | 42.3 Million | 49.27 Million | 49.27 Million | -27.62 Million |
| Investments in PPE | -714 Thousand | -714 Thousand | -15.31 Million | -953.5 Thousand | -953.5 Thousand | -720 Thousand |
| Acquisitions | - | - | -2 Million | 500 Thousand | 500 Thousand | -500 Thousand |
| Investment purchases | - | - | -60.95 Million | - | - | -62.73 Million |
| Sales/Maturities of investments | - | - | 117.73 Million | - | - | 15.39 Million |
| Other Investing Activities | -44.03 Million | -44.03 Million | 45.65 Million | 49.72 Million | 49.72 Million | -26.9 Million |
| Financing Cash Flow | -2.68 Million | -2.68 Million | -211.26 Million | -92.63 Million | -92.63 Million | -13.5 Million |
| Debt repayment | - | - | -176.02 Million | - | - | -5.26 Million |
| Dividends payments | - | - | -16.89 Million | -2.11 Million | -2.11 Million | -6.33 Million |
| Common Stock Repurchased | -1.22 Million | -1.22 Million | -12.47 Million | -724.5 Thousand | -724.5 Thousand | -5.51 Million |
| Common Stock Issuance | - | - | 687 Thousand | - | - | 250.33 Thousand |
| Other Financing Activities | -1.46 Million | -1.46 Million | -2 Million | -89.79 Million | -89.79 Million | -1.65 Million |
| Accounts receivables | 2.4 Million | 2.4 Million | 5.19 Million | 191.5 Thousand | 191.5 Thousand | 2.4 Million |
| Accounts payables | - | - | - | - | - | 307.49 Thousand |
| Inventory | 148 Thousand | 148 Thousand | -2.7 Million | -373.5 Thousand | -373.5 Thousand | -976.5 Thousand |
| Other working capital | -1.18 Million | -1.18 Million | -301 Thousand | 602.5 Thousand | 602.5 Thousand | -753.5 Thousand |
| Cash at beginning of period | - | - | 185.82 Million | - | 118.71 Million | 183.48 Million |
| Cash at end of period | 2.14 Million | 2.14 Million | 50.27 Million | -34.23 Million | -34.23 Million | 118.71 Million |
| Capital Expenditure | -714 Thousand | -714 Thousand | -15.31 Million | -953.5 Thousand | -953.5 Thousand | -720 Thousand |
| Effect of forex changes on cash | -19.5 Thousand | -19.5 Thousand | -210 Thousand | 57.5 Thousand | 57.5 Thousand | -162.5 Thousand |
| Net cash flow / Change in cash | 2.14 Million | 2.14 Million | -135.55 Million | -34.23 Million | -152.94 Million | -64.77 Million |
| Free Cash Flow | 48.87 Million | 48.87 Million | 18.31 Million | 8.11 Million | 8.11 Million | 7.02 Million |
STW
002580
GBR
6670
603025
HTLF